P2Y12 Receptor Antagonists
Showing 1 - 25 of >10,000
Acute Coronary Syndrome, STEMI, NSTEMI - Non-ST Segment Elevation MI Trial in Zagreb (Clopidogrel, Ticagrelor)
Completed
- Acute Coronary Syndrome
- +4 more
-
Zagreb, CroatiaUhiversity hospital Center Zagreb
Apr 27, 2020
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1
Not yet recruiting
- ST Elevation Myocardial Infarction
- Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
-
Geneva, SwitzerlandGeneva University Hospitals
Mar 25, 2023
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
P2Y12 Receptor Inhibitors on Central and Peripheral
Recruiting
- Dyspnea
- Clopidogrel, Ticagrelor
-
Wrocław, Dolnośląskie, PolandWroclaw Medical University
Oct 13, 2021
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023
Left Main Coronary Artery Stenosis Trial in Geneva (LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International,
Not yet recruiting
- Left Main Coronary Artery Stenosis
- LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International, Switzerland)
- +2 more
-
Geneva, SwitzerlandGeneva University Hospitals
Jan 12, 2023
Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,
Active, not recruiting
- Chronic Kidney Disease (CKD)
- +2 more
- Clopidogrel
- Clopidogrel active metabolite
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Aug 5, 2022
Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +
Recruiting
- Myocardial Infarction
- +2 more
- P2Y12 Potent Inhibitor + Aspirin for STEMI patients
- Clopidogrel + Aspirin for CCS patients
-
Messina, ItalyAOU Policlinico G. Martino
Jan 21, 2023
Cardiovascular Drugs Adverse Reaction
Recruiting
- Pharmacogenetics
- +2 more
- Oral Anticoagulant, Direct-Acting
-
Zagreb, CroatiaUHC Zagreb
Mar 23, 2022
Cardiovascular Diseases, Acute Coronary Syndrome Trial in Cairo (Ticagrelor 90mg (Brilique), Ticagrelor 90mg (Ticaloguard))
Completed
- Cardiovascular Diseases
- Acute Coronary Syndrome
- Ticagrelor 90mg (Brilique)
- Ticagrelor 90mg (Ticaloguard)
-
Cairo, EgyptFaculty of Medicine
Jul 21, 2022
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Platelet Agregation in Patients on ECMO
Recruiting
- Platelet Refractoriness
- P2Y12 Platelet Aggregation Inhibitor
-
Ljubljana, SloveniaUMC Ljubljana
Sep 13, 2022
Genetic Variant Scores and P2Y12 Inhibitor Effects
Recruiting
- Stent Thrombosis
- +3 more
-
Seongnam-si, Gyonggi-do, Korea, Republic ofSNUBH
Jul 18, 2022
Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)
Not yet recruiting
- Coronary Artery Disease
- aspirin plus clopidogrel
- prasugrel or ticagrelor
-
Jacksonville, FloridaUniversity of Florida
Jan 4, 2023
![](/image/sponsor/azienda_ospedaliera_universitaria_policlinico_"g_martino")
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Dutch Adult Cardiac Surgery Population, and Effect on
Not yet recruiting
- P2Y12 Receptor Inhibitor
- +2 more
- TRACK-TCT
-
Enschede, Overijssel, NetherlandsThoraxcentrum Twente
Oct 12, 2022
Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Recruiting
- Cardiac Arrest
- +3 more
- Antiplatelet Drug
-
Monza, MB, ItalyIRCCS San Gerardo dei Tintori
Feb 14, 2023
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy Trial in Dordrecht, Rotterdam (Prasugrel based short DAPT,
Recruiting
- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy
- Prasugrel based short DAPT
- +3 more
-
Dordrecht, Netherlands
- +2 more
Aug 5, 2022
Patients Undergoing Coronary Angiography and Percutaneous
Not yet recruiting
- Chronic Coronary Insufficiency
- Smoking
- (no location specified)
Apr 13, 2022
Platelet Aggregation Onhibitors Trial in Prague (antiplatelet drugs - P2Y12 antagonists)
Completed
- Platelet Aggregation Onhibitors
- antiplatelet drugs - P2Y12 antagonists
-
Prague, CzechiaFaculty Hospital Kralovske Vinohrady
Jul 20, 2020
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023